NCT05324618View on ClinicalTrials.gov

Tacrolimus Versus Hydrocortisone in Atopic Dermatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 15, 2022

Primary Completion Date

November 20, 2022

Study Completion Date

April 30, 2023

Conditions
AtopicDermatitis
Interventions
DRUG

Tacrolimus

0.03% topical tacrolimus ointment applied on the affected areas twice daily for 4 months.

DRUG

Hydrocortisone

1% hydrocortisone cream applied on the affected areas twice daily for 4 months.

Trial Locations (1)

123456

Dermatology Clinic of National Hepatology and Tropical Medicine Research Institute, Cairo

All Listed Sponsors
collaborator

National Hepatology & Tropical Medicine Research Institute

OTHER_GOV

lead

Ain Shams University

OTHER